Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELATLIMAB vs RELUGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELATLIMAB vs RELUGOLIX: Safety Overview

Metric RELATLIMAB RELUGOLIX
Total FAERS Reports 177 20,660
Deaths Reported 29 958
Death Rate 16.4% 4.6%
Hospitalizations 145 1,699
Average Patient Age 64.5 yrs 72.4 yrs
% Female Patients 34.6% 1.4%
FDA Approval Date N/A Dec 18, 2020
Manufacturer N/A Sumitomo Pharma America, Inc.
Route N/A ORAL
Marketing Status N/A Prescription